We gebruiken cookies om ervoor te zorgen dat onze site zo soepel mogelijk draait. Als je doorgaat met het gebruiken van deze site, gaan we er vanuit dat je ermee instemt.


Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 55

Warning: Undefined variable $show_taxonomy in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 106

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 55

Warning: Undefined variable $show_taxonomy in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 106

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 55
Specialismen
Oncologie

Oncologie

BorstHoofd-halsImmuno-oncologieLongMDLPediatrieSarcoom

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 239

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 239

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 239
Borst

Oncologie bericht test

7 augustus 2023
0 min 0 sec

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 446

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 446

Warning: Trying to access array offset on false in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 446

Oncologie

BorstHoofd-halsImmuno-oncologieLongMDLPediatrieSarcoom
COVID
06-11-2025
Oligoprogressieve ziekte en langdurige respons bij eerstelijns osimertinib voor EGFR-gemuteerd NSCLC
EGFR-mutatie is de meest voorkomende behandelbare oncogene afwijking bij niet-kleincellig longcarcinoom (NSCLC), goed voor 10–15% van de Westerse patiënten. Osimertinib, een derde-generatie EGFR-tyrosinekinaseremmer (TKI), is de standaard eerstelijnsbehandeling voor gevorderd EGFR-gemuteerd NSCLC en toont hoge initiële effectiviteit. Uiteindelijk ontstaat echter vrijwel altijd resistentie, die zich kan uiten als oligoprogressieve ziekte (OPD), waarbij de tumor beperkt […]
Huisarts
3 min leestijd

Oncologie nieuws

Long
05-11-2025
Waarom zijn er zo weinig mutaties in ons kleine kikkerlandje?
2 min leestijd
Long
05-11-2025
Testen in de toekomst: visie op een toekomstbestendige aanpak
3 min leestijd
Long
05-11-2025
Visie en prioriteiten van de EORTC
3 min leestijd
Immuno-oncologie
05-11-2025
De rol van tumorsuppressorgenen bij het effect van immuuntherapie
3 min leestijd
COVID
06-11-2025
Oligoprogressieve ziekte en langdurige respons bij...
Long
05-11-2025
Waarom zijn er zo weinig mutaties in ons kleine ki...
Long
05-11-2025
Testen in de toekomst: visie op een toekomstbesten...
Long
05-11-2025
Visie en prioriteiten van de EORTC
Immuno-oncologie
05-11-2025
De rol van tumorsuppressorgenen bij het effect van...

Aanbevolen

Long
05-11-2025
Nieuwe behandelstrategieën: ADC’s
prof.dr. E.F. Smit, longarts LUMC Er zijn meer dan 140 antibody drug conjugates (ADC’s) in klinische trials, maar er zijn problemen met toxiciteit e...
Oncologie
3 min leestijd
Immuno-oncologie
05-11-2025
Neo-adjuvant behandelen: wie en hoe?
dr. Wouter de Jong, longarts UMCU Immunotherapie kan op verschillende manieren geïntegreerd worden in de behandelschema’s voor NSCLC.  Dr. Wou...
2 min leestijd
Long
05-11-2025
Testen in de toekomst: moleculaire diagnostiek
Oncologie
3 min leestijd
Long
05-11-2025
Integratie van zorg en onderzoek:het nut en de noodzaak van hoge kwaliteit real world data
Oncologie
3 min leestijd

Borst blogs


Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Apotheek
08-02-2022
Gemetastaseerde borstkanker mogelijk te behandelen met bestaande geneesmiddelen
Apotheek
1 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Apotheek
17-05-2022
Effect ribociclib en letrozol op totale overleving bij gevorderde borstkanker
Apotheek
2 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Huisarts
07-11-2023
Follow-up van afwijkende kankerscreeningsresultaten verbeteren
Huisarts
3 min leestijd

Hoofd-hals blogs


Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Apotheek
01-02-2022
Immuuntherapie voorafgaand aan operatie hoofd-halstumoren is veilig en effectief
Apotheek
3 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
14-10-2024
Ultrasnelle hormoon-meter geeft zekerheid bij operaties van patiënten met te snel werkende bijschildklier
2 min leestijd

Immuno-oncologie blogs


Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Immunologie
07-06-2022
Blokkeren van eiwit door nieuw kankervaccin vergroot overlevingskansen bij honden
Immunologie
3 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Dermatologie
20-09-2022
Immuungerelateerde bijwerkingen van checkpointremmers
Dermatologie
2 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Algemeen
23-09-2024
De toekomst van geneesmiddelenontwikkeling: AI
Algemeen
2 min leestijd

Long blogs


Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Apotheek
03-01-2019
Stadium IV ALK+ longkanker – een stuk positiever vooruitzicht dan 15 jaar geleden
Apotheek
2 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Huisarts
07-11-2023
Follow-up van afwijkende kankerscreeningsresultaten verbeteren
Huisarts
3 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
28-10-2025
Biomarkers voor immuuntherapie:wat weten we, wat weten we nog niet, en welke recente inzichten hebben we m.b.t. PD-L1 en TMB?
2 min leestijd

MDL blogs


Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
MDL
04-01-2022
Nieuwe hybride C-boog versnelt radio-embolisatie behandeling
MDL
3 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Immunologie
07-06-2022
Blokkeren van eiwit door nieuw kankervaccin vergroot overlevingskansen bij honden
Immunologie
3 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Apotheek
02-08-2022
Eerste volledige multi-orgaantransplantatie ter behandeling van kanker
Apotheek
5 min leestijd

Pediatrie blogs


Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Chirurgie
18-10-2022
Non-Hodgkin lymfoom (NHL) na niertransplantatie
Chirurgie
3 min leestijd

Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Apotheek
17-01-2023
Variatie in geneesmiddelrespons bij kinderen met acute lymfoblastische leukemie
Apotheek
1 min leestijd

Sarcoom blog


Warning: Undefined variable $card_class in /usr/www/users/medzip/Prod/wp-content/plugins/oxygen/component-framework/components/classes/code-block.class.php(133) : eval()'d code on line 437
Oncologie
28-05-2024
Compleet DNA-onderzoek: diagnostiek en behandeling bij uitgezaaide kanker
Oncologie
4 min leestijd

Interessant voor u

FTO
FTO-Online
Eerstelijns publicaties
FO
Farmacotherapie
Tweedelijns publicaties
CME
CME-Academy
Medische nascholingen
Home/Specialismen/
Oncologie

Oncologie nieuws

Borst

Erratum: Prospective Study of Supplemental Screening With Contrast-Enhanced Mammography in Women With Elevated Risk of Breast Cancer: Results of the Prevalence Round
4 dagen geleden
ascopubs.org
Journal of Clinical Oncology, Volume 43, Issue 28, Page 3140-3140, October 2025.
Identifying Patients With Low Relapse Rate Despite High-Risk Estrogen Receptor–Positive/Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: Development and Validation of a Clinicopathologic Assay
9 dagen geleden
ascopubs.org
Journal of Clinical Oncology, Volume 43, Issue 28, Page 3090-3101, October 2025.
Deep Learning Model for Breast Shear Wave Elastography to Improve Breast Cancer Diagnosis (INSPiRED 006): An International, Multicenter Analysis
9 dagen geleden
ascopubs.org
Journal of Clinical Oncology, Ahead of Print.
Toon meer

Hoofd-hals

Second Mitochondrial Activator of Caspases Mimetics Accelerate Progression of Locally Advanced Head and Neck Cancer
3 dagen geleden
ascopubs.org
Journal of Clinical Oncology, Ahead of Print.
A Practical Method for Detecting Prognostic CD57+ T Cells in Head and Neck Cancer
19 dagen geleden
onlinelibrary.wiley.com
Recurrence of head and neck squamous cell carcinoma (HNSCC) affects nearly half of patients and greatly reduces survival. There are currently no well-...
Patient?Reported Dysphagia and Swallowing?Related Quality of Life up to 10?Years After (Chemo)radiotherapy for Head and Neck Cancer: A Cross?Sectional Study
23 dagen geleden
onlinelibrary.wiley.com
This study sought to better understand patient-reported dysphagia and swallowing-related quality of life (swQOL) in patients 6?months to 10?years foll...
Toon meer

Immuno-oncologie

Exploring blood cell biomarkers in melanoma patients receiving adjuvant anti?PD?1 immunotherapy
1 dag geleden
onlinelibrary.wiley.com
Limited Response to Enfortumab Vedotin?Pembrolizumab in Three Consecutive Cases of Neoadjuvant Chemotherapy?Resistant Muscle?Invasive Bladder Cancer
1 dag geleden
onlinelibrary.wiley.com
Assessing Response Durability and Survival After Second?Line Pembrolizumab in Advanced Urothelial Carcinoma: A Multicenter Validation of a Risk Model
1 dag geleden
onlinelibrary.wiley.com
Second-line pembrolizumab improves the overall survival (OS) of patients with metastatic urothelial carcinoma (UC). We sought to develop and validate ...
Toon meer

Long

Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib
5 dagen geleden
lungcancerjournal.info
Epidermal growth factor receptor (EGFR) mutation is the most common actionable oncogenic alteration in non-small cell lung cancer (NSCLC), accounting for approximately 50?% of cases in Asian and 10–15?% of cases in Western populations [1]. The global phase III FLAURA trial established osimertinib as the standard first-line treatment for patients with advanced EGFR mutation positive NSCLC, demonstrating superior progression-free survival (PFS), overall survival (OS), and intracranial response rates, compared to first-generation EGFR tyrosine kinase inhibitors (TKIs) [2,3].
Pattern of failure, impact of local therapy, and characteristics of long-term responders with advanced EGFR mutation positive non-small cell lung cancer treated with first-line osimertinib
5 dagen geleden
lungcancerjournal.info
Epidermal growth factor receptor (EGFR) mutation is the most common actionable oncogenic alteration in non-small cell lung cancer (NSCLC), accounting for approximately 50?% of cases in Asian and 10–15?% of cases in Western populations [1]. The global phase III FLAURA trial established osimertinib as the standard first-line treatment for patients with advanced EGFR mutation positive NSCLC, demonstrating superior progression-free survival (PFS), overall survival (OS), and intracranial response rates, compared to first-generation EGFR tyrosine kinase inhibitors (TKIs) [2,3].
Delivering equitable access to prehabilitation services to optimise outcomes for patients with lung cancer – Best practice recommendations from a UK roundtable event
10 dagen geleden
lungcancerjournal.info
Prehabilitation is a component of the rehabilitation continuum, taking place either before a patient has received treatment and/or during treatment.[1] It aims to prepare patients for their treatment and facilitate a quicker return to health, with potential benefits including improved quality of life (QoL), reduced surgical complications, and decreased length of stay (LoS).[1–3].
Toon meer

MDL

Impact of Human Epidermal Growth Factor Receptor 2 in Patients With Metastatic Colorectal Cancer Treated With Chemotherapy Plus Bevacizumab or Anti-EGFRs: Exploratory Analysis of Eight Randomized Trials
2 dagen geleden
ascopubs.org
Journal of Clinical Oncology, Ahead of Print.
KEYNOTE-585 Fails While Matterhorn Succeeds in Gastric Cancer: What Lessons Can We Learn?
18 dagen geleden
ascopubs.org
Journal of Clinical Oncology, Ahead of Print.
Two lenses, same picture: interpreting nal-IRI in biliary tract cancer
20 dagen geleden
journal-of-hepatology.eu
We read with great interest the recent article by Yoo et al. reporting an individual patient-level pooled analysis of two multicenter randomized trials. [1]
Toon meer

Pediatrie

Cancer in children living with HIV: challenges and perspectives in the antiretroviral therapy era
1 maand geleden
pubmed.ncbi.nlm.nih.gov
World J Pediatr. 2025 Sep 27. doi: 10.1007/s12519-025-00971-x. Online ahead of print.
Pediatric-Type Diffuse Low Grade Glioma
1 maand geleden
sciencedirect.com
Publication date: Available online 25 September 2025
UK MHRA grants marketing authorization to vorasidenib to treat patients 12 years and older with grade 2 astrocytoma or oligodendroglioma with a susceptible IDH1 or IDH2 mutation
1 maand geleden
pharmabiz.com
The UK Medicines and Healthcare products Regulatory Agency (MHRA) on 16th September 2025 has approved the medicine vorasidenib (Voranigo) to treat adults and children 12 years of age and older with certain types of brain
Toon meer

Sarcoom

Is There a Role for Mifamurtide in Nonmetastatic High-Grade Osteosarcoma? Results From the Italian Sarcoma Group (ISG/OS-2) and Spanish Sarcoma Group (GEIS-33) Trials
19 dagen geleden
ascopubs.org
Journal of Clinical Oncology, Volume 43, Issue 28, Page 3113-3122, October 2025.
ENO1 promotes cancer metastasis via stimulating metabolism reprogramming in osteosarcoma
1 maand geleden
nature.com
British Journal of Cancer, Published online: 22 September 2025; doi:10.1038/s41416-025-03182-3
ENO1 promotes cancer metastasis via stimulating metabolism reprogramming in osteosarcoma
1 maand geleden
nature.com
British Journal of Cancer, Published online: 22 September 2025; doi:10.1038/s41416-025-03182-3